RESPeRATE Resarch: A non-drug option welcomed by patients & doctors
RESPeRATE is the first and only medical device indicated for the adjunctive treatment of hypertension and the reduction of stress by the regulatory authorities in the US, Europe, Australia, Canada and major Asian countries. RESPeRATE can be combined with standard antihypertensive drugs and/or non-pharmacologic interventions.
RESPeRATE appears particularly useful for:
- Pre-hypertensives and white-coat or labile hypertensives
- Patients with isolated systolic hypertension, and Resistant hypertensive patients
- There are no known contraindications or adverse reactions to the use of RESPeRATE
- See detailed FDA indication for use
“I’m a clinical pharmacologist at Rush Medical Center, our multi-center, controlled clinical study concluded that RESPeRATE is easy to use, did not have any side-effects and delivered a significant blood pressure reduction, when used for 15 minutes at least 3 times a week. Now that is kind of amazing as…”
William Elliott MD, Rush Medical Center, Chicago, Illinois
RESPeRATE’s Peer-reviewed Articles :
Journal of Human Hypertension; 2001, 15:271-278.
Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B.
Journal of Human Hypertension; 2001, 15:263-269.
pressure – Ambulatory and home measurements.”
Rosenthal T, Alter A, Peleg E, Gavish B.
American Journal of Hypertension; 2001, 14:74-76
American Journal of Hypertension; 2004, 17:370-374.
W Elliott, J Izzo, Jr., WB White, D Rosing, CS Snyder, A Alter, B Gavish, HR Black
J Clin Hypertens; 2004 6(10): 553-559.
American Journal of Hypertension; 2003; 16:484-487.
Journal of Hypertension; 2004, 22(2):S116.